Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor page/template update rather than changes to study details.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a minor site/template update.SummaryDifference0.0%

- Check29 days agoChange DetectedA recruitment notice 'No longer looking for participants' was added. New user-help sections were introduced, the Intervention/Treatment label was standardized, and the revision version updated to v3.6.0.SummaryDifference0.4%

- Check36 days agoChange DetectedThe revision indicator at the bottom of the page was updated from v3.5.4 to v3.5.5, signaling a deployment update. This reflects an underlying site update rather than a change to the study content or results.SummaryDifference0.1%

- Check58 days agoChange DetectedPublications section updated: a new bibliographic citation for Shen L et al. on tislelizumab in Chinese patients was added, including author names and source details. The Erratum entry previously listed was removed and the revision version updated to v3.5.4.SummaryDifference0.1%

- Check79 days agoChange DetectedThe footer revision/version label on the ClinicalTrials.gov study page was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.